Page results
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
How UCLH uses clinical data in research.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
Information for patients from overseas visiting UCLH hospitals.
File results
-
FOI/2022/0478 - Hospital-initiated cancellation of appointments
-
FOI/2022/0481 - Electronic Patient Record system
-
FOI/2022/0482 - Non-emergency patient transport service (NEPTS)
-
FOI/2022/0485 - ACR laboratory device
-
FOI/2022/0486 - Dermatology dept staff details
-
FOI/2022/0487 - ICT spend on telecommunication, mobile handsets/ smartphones
-
FOI/2022/0488 - Robotic process automation
-
FOI/2022/0489 - Prescribed PrEP medication
-
FOI/2022/0494 - Treatment of Haemophilia A
-
FOI/2022/0495 - International recruitment